fig3

Figure 3. Soft tissue sarcomas (STS) are thought to be derived from lineage committed mesenchymal stem cells. Aberrant EZH2 expression and/or activity is believed to prevent normal terminal differentiation, leading to continued proliferation and poorly differentiated phenotypes in STS.